“Fisetin induces G2/M phase cell cycle arrest by inactivating cdc25C-cdc2 via ATM-Chk1/2 activation in human endometrial cancer cells”, Bangladesh J Pharmacol, vol. 10, no. 2, pp. 279–287, Apr. 2015, doi: 10.3329/bjp.v10i2.21945.